IBDEI0IB ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8565,2)
 ;;=^268285
 ;;^UTILITY(U,$J,358.3,8566,0)
 ;;=780.52^^35^487^100
 ;;^UTILITY(U,$J,358.3,8566,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8566,1,4,0)
 ;;=4^780.52
 ;;^UTILITY(U,$J,358.3,8566,1,5,0)
 ;;=5^Insomnia, Organic
 ;;^UTILITY(U,$J,358.3,8566,2)
 ;;=Insomnia, Organic^87662
 ;;^UTILITY(U,$J,358.3,8567,0)
 ;;=302.71^^35^487^103
 ;;^UTILITY(U,$J,358.3,8567,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8567,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,8567,1,5,0)
 ;;=5^Loss of Libido
 ;;^UTILITY(U,$J,358.3,8567,2)
 ;;=^268178
 ;;^UTILITY(U,$J,358.3,8568,0)
 ;;=785.6^^35^487^106
 ;;^UTILITY(U,$J,358.3,8568,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8568,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,8568,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,8568,2)
 ;;=Lymphadenopathy^72368
 ;;^UTILITY(U,$J,358.3,8569,0)
 ;;=728.85^^35^487^112
 ;;^UTILITY(U,$J,358.3,8569,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8569,1,4,0)
 ;;=4^728.85
 ;;^UTILITY(U,$J,358.3,8569,1,5,0)
 ;;=5^Muscle Spasm
 ;;^UTILITY(U,$J,358.3,8569,2)
 ;;=Muscle Spasm^112558
 ;;^UTILITY(U,$J,358.3,8570,0)
 ;;=782.0^^35^487^51
 ;;^UTILITY(U,$J,358.3,8570,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8570,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,8570,1,5,0)
 ;;=5^Disturbance of Skin Sensation
 ;;^UTILITY(U,$J,358.3,8570,2)
 ;;=Disturbance of Skin Sensation^35757
 ;;^UTILITY(U,$J,358.3,8571,0)
 ;;=278.00^^35^487^117
 ;;^UTILITY(U,$J,358.3,8571,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8571,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,8571,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,8571,2)
 ;;=Obesity^84823
 ;;^UTILITY(U,$J,358.3,8572,0)
 ;;=278.01^^35^487^118
 ;;^UTILITY(U,$J,358.3,8572,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8572,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,8572,1,5,0)
 ;;=5^Obesity, Morbid
 ;;^UTILITY(U,$J,358.3,8572,2)
 ;;=Obesity, Morbid^84844
 ;;^UTILITY(U,$J,358.3,8573,0)
 ;;=783.5^^35^487^127
 ;;^UTILITY(U,$J,358.3,8573,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8573,1,4,0)
 ;;=4^783.5
 ;;^UTILITY(U,$J,358.3,8573,1,5,0)
 ;;=5^Polydipsia
 ;;^UTILITY(U,$J,358.3,8573,2)
 ;;=Polydipsia^186699
 ;;^UTILITY(U,$J,358.3,8574,0)
 ;;=783.6^^35^487^128
 ;;^UTILITY(U,$J,358.3,8574,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8574,1,4,0)
 ;;=4^783.6
 ;;^UTILITY(U,$J,358.3,8574,1,5,0)
 ;;=5^Polyphagia
 ;;^UTILITY(U,$J,358.3,8574,2)
 ;;=Polyphagia^60236
 ;;^UTILITY(U,$J,358.3,8575,0)
 ;;=780.2^^35^487^144
 ;;^UTILITY(U,$J,358.3,8575,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8575,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,8575,1,5,0)
 ;;=5^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,8575,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,8576,0)
 ;;=783.1^^35^487^156
 ;;^UTILITY(U,$J,358.3,8576,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8576,1,4,0)
 ;;=4^783.1
 ;;^UTILITY(U,$J,358.3,8576,1,5,0)
 ;;=5^Weight gain, abnormal
 ;;^UTILITY(U,$J,358.3,8576,2)
 ;;=^998
 ;;^UTILITY(U,$J,358.3,8577,0)
 ;;=783.21^^35^487^157
 ;;^UTILITY(U,$J,358.3,8577,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8577,1,4,0)
 ;;=4^783.21
 ;;^UTILITY(U,$J,358.3,8577,1,5,0)
 ;;=5^Weight loss, abnormal
 ;;^UTILITY(U,$J,358.3,8577,2)
 ;;=^322005
 ;;^UTILITY(U,$J,358.3,8578,0)
 ;;=796.2^^35^487^32
 ;;^UTILITY(U,$J,358.3,8578,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8578,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,8578,1,5,0)
 ;;=5^Blood Pressure Elevated, w/o HTN
 ;;^UTILITY(U,$J,358.3,8578,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,8579,0)
 ;;=790.92^^35^487^9
 ;;^UTILITY(U,$J,358.3,8579,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8579,1,4,0)
 ;;=4^790.92
 ;;
 ;;$END ROU IBDEI0IB
